TUMS Antacid, Calcium Carbonate USP 1000 mg, Peppermint flavor, chewable tablets, packaged in 12-...

FDA Drug Recall #D-0074-2024 — Class II — December 2, 2022

Recall Summary

Recall Number D-0074-2024
Classification Class II — Moderate risk
Date Initiated December 2, 2022
Status Completed
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm GlaxoSmithKline Consumer Healthcare Holdings LLC
Location Saint Louis, MO
Product Type Drugs
Quantity N/A

Product Description

TUMS Antacid, Calcium Carbonate USP 1000 mg, Peppermint flavor, chewable tablets, packaged in 12-count roll, Dist. by: GSK CH, Warren, NJ 07059. NDC: 0135-0228-01, UPC 3-0766-0746-80-5

Reason for Recall

Presence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.

Distribution Pattern

Nationwide within the United States

Lot / Code Information

Lot #: HA7G, Exp. Date 8/31/2027

Other Recalls from GlaxoSmithKline Consumer Healthcare ...

Recall # Classification Product Date
D-0076-2024 Class II TUMS Antacid, Calcium Carbonate USP 1000 mg, As... Dec 2, 2022
D-0073-2024 Class II TUMS Antacid, Calcium Carbonate USP 1000 mg, Pe... Dec 2, 2022
D-0079-2024 Class II TUMS Antacid, Calcium Carbonate USP 1000 mg, As... Dec 2, 2022
D-0075-2024 Class II TUMS Antacid, Calcium Carbonate USP 1000 mg, As... Dec 2, 2022
D-0078-2024 Class II TUMS Antacid, Calcium Carbonate USP 1000 mg, As... Dec 2, 2022

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.